Shingles, Zostavax vaccination and risk of developing dementia: a nested case–control study—results from the UK Biobank cohort

ObjectivesTo investigate the association between shingles and dementia, and between Zostavax vaccination and dementia.DesignNested case–control study.SettingsData were drawn from the UK Biobank cohort study with a total of 228 223 participants with Hospital Episodes Statistics and primary care linka...

Full description

Saved in:
Bibliographic Details
Published inBMJ open Vol. 11; no. 10; p. e045871
Main Authors Lophatananon, Artitaya, Mekli, Krisztina, Cant, Rachel, Burns, Alistair, Dobson, Curtis, Itzhaki, Ruth, Muir, Kenneth
Format Journal Article
LanguageEnglish
Published England British Medical Journal Publishing Group 08.10.2021
BMJ Publishing Group LTD
BMJ Publishing Group
SeriesOriginal research
Subjects
Online AccessGet full text
ISSN2044-6055
2044-6055
DOI10.1136/bmjopen-2020-045871

Cover

Abstract ObjectivesTo investigate the association between shingles and dementia, and between Zostavax vaccination and dementia.DesignNested case–control study.SettingsData were drawn from the UK Biobank cohort study with a total of 228 223 participants with Hospital Episodes Statistics and primary care linkage health records.ParticipantsThe analyses included 2378 incident dementia cases and 225 845 controls. Inclusion criteria for incident cases were a dementia diagnosis 3 years or more after the first assessment date derived from all sources including International Classification of Diseases (ICD)-10, ICD-9, self-report and primary care linkage records. Subjects with no dementia code from all sources were coded as controls. Both shingles and Zostavax vaccination were investigated for their association with dementia risk.ResultsThere was a small but non-significant increase in the risk of dementia in subjects with shingles diagnosed 3 years or more prior to dementia diagnosis (OR: 1.088 with 95% CI: 0.978 to 1.211). In those subjects who had had Zostavax vaccination, the risk of dementia significantly decreased (OR: 0.808 with 95% CI: 0.657 to 0.993).ConclusionA history of shingles was not associated with an increased risk of dementia. In subjects who were eligible for the immunisation and vaccinated with Zostavax, we saw reduced risk of developing dementia.
AbstractList ObjectivesTo investigate the association between shingles and dementia, and between Zostavax vaccination and dementia.DesignNested case–control study.SettingsData were drawn from the UK Biobank cohort study with a total of 228 223 participants with Hospital Episodes Statistics and primary care linkage health records.ParticipantsThe analyses included 2378 incident dementia cases and 225 845 controls. Inclusion criteria for incident cases were a dementia diagnosis 3 years or more after the first assessment date derived from all sources including International Classification of Diseases (ICD)-10, ICD-9, self-report and primary care linkage records. Subjects with no dementia code from all sources were coded as controls. Both shingles and Zostavax vaccination were investigated for their association with dementia risk.ResultsThere was a small but non-significant increase in the risk of dementia in subjects with shingles diagnosed 3 years or more prior to dementia diagnosis (OR: 1.088 with 95% CI: 0.978 to 1.211). In those subjects who had had Zostavax vaccination, the risk of dementia significantly decreased (OR: 0.808 with 95% CI: 0.657 to 0.993).ConclusionA history of shingles was not associated with an increased risk of dementia. In subjects who were eligible for the immunisation and vaccinated with Zostavax, we saw reduced risk of developing dementia.
To investigate the association between shingles and dementia, and between Zostavax vaccination and dementia.OBJECTIVESTo investigate the association between shingles and dementia, and between Zostavax vaccination and dementia.Nested case-control study.DESIGNNested case-control study.Data were drawn from the UK Biobank cohort study with a total of 228 223 participants with Hospital Episodes Statistics and primary care linkage health records.SETTINGSData were drawn from the UK Biobank cohort study with a total of 228 223 participants with Hospital Episodes Statistics and primary care linkage health records.The analyses included 2378 incident dementia cases and 225 845 controls. Inclusion criteria for incident cases were a dementia diagnosis 3 years or more after the first assessment date derived from all sources including International Classification of Diseases (ICD)-10, ICD-9, self-report and primary care linkage records. Subjects with no dementia code from all sources were coded as controls. Both shingles and Zostavax vaccination were investigated for their association with dementia risk.PARTICIPANTSThe analyses included 2378 incident dementia cases and 225 845 controls. Inclusion criteria for incident cases were a dementia diagnosis 3 years or more after the first assessment date derived from all sources including International Classification of Diseases (ICD)-10, ICD-9, self-report and primary care linkage records. Subjects with no dementia code from all sources were coded as controls. Both shingles and Zostavax vaccination were investigated for their association with dementia risk.There was a small but non-significant increase in the risk of dementia in subjects with shingles diagnosed 3 years or more prior to dementia diagnosis (OR: 1.088 with 95% CI: 0.978 to 1.211). In those subjects who had had Zostavax vaccination, the risk of dementia significantly decreased (OR: 0.808 with 95% CI: 0.657 to 0.993).RESULTSThere was a small but non-significant increase in the risk of dementia in subjects with shingles diagnosed 3 years or more prior to dementia diagnosis (OR: 1.088 with 95% CI: 0.978 to 1.211). In those subjects who had had Zostavax vaccination, the risk of dementia significantly decreased (OR: 0.808 with 95% CI: 0.657 to 0.993).A history of shingles was not associated with an increased risk of dementia. In subjects who were eligible for the immunisation and vaccinated with Zostavax, we saw reduced risk of developing dementia.CONCLUSIONA history of shingles was not associated with an increased risk of dementia. In subjects who were eligible for the immunisation and vaccinated with Zostavax, we saw reduced risk of developing dementia.
Objectives To investigate the association between shingles and dementia, and between Zostavax vaccination and dementia.Design Nested case–control study.Settings Data were drawn from the UK Biobank cohort study with a total of 228 223 participants with Hospital Episodes Statistics and primary care linkage health records.Participants The analyses included 2378 incident dementia cases and 225 845 controls. Inclusion criteria for incident cases were a dementia diagnosis 3 years or more after the first assessment date derived from all sources including International Classification of Diseases (ICD)-10, ICD-9, self-report and primary care linkage records. Subjects with no dementia code from all sources were coded as controls. Both shingles and Zostavax vaccination were investigated for their association with dementia risk.Results There was a small but non-significant increase in the risk of dementia in subjects with shingles diagnosed 3 years or more prior to dementia diagnosis (OR: 1.088 with 95% CI: 0.978 to 1.211). In those subjects who had had Zostavax vaccination, the risk of dementia significantly decreased (OR: 0.808 with 95% CI: 0.657 to 0.993).Conclusion A history of shingles was not associated with an increased risk of dementia. In subjects who were eligible for the immunisation and vaccinated with Zostavax, we saw reduced risk of developing dementia.
To investigate the association between shingles and dementia, and between Zostavax vaccination and dementia. Nested case-control study. Data were drawn from the UK Biobank cohort study with a total of 228 223 participants with Hospital Episodes Statistics and primary care linkage health records. The analyses included 2378 incident dementia cases and 225 845 controls. Inclusion criteria for incident cases were a dementia diagnosis 3 years or more after the first assessment date derived from all sources including International Classification of Diseases (ICD)-10, ICD-9, self-report and primary care linkage records. Subjects with no dementia code from all sources were coded as controls. Both shingles and Zostavax vaccination were investigated for their association with dementia risk. There was a small but non-significant increase in the risk of dementia in subjects with shingles diagnosed 3 years or more prior to dementia diagnosis (OR: 1.088 with 95% CI: 0.978 to 1.211). In those subjects who had had Zostavax vaccination, the risk of dementia significantly decreased (OR: 0.808 with 95% CI: 0.657 to 0.993). A history of shingles was not associated with an increased risk of dementia. In subjects who were eligible for the immunisation and vaccinated with Zostavax, we saw reduced risk of developing dementia.
Author Dobson, Curtis
Cant, Rachel
Burns, Alistair
Muir, Kenneth
Itzhaki, Ruth
Mekli, Krisztina
Lophatananon, Artitaya
AuthorAffiliation 1 Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health , The University of Manchester , Manchester , UK
4 The Oxford Institute of Population Ageing , University of Oxford , Oxford , UK
3 Division of Neuroscience & Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health , The University of Manchester , Manchester , UK
2 Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health , The University of Manchester , Manchester , UK
AuthorAffiliation_xml – name: 1 Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health , The University of Manchester , Manchester , UK
– name: 2 Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health , The University of Manchester , Manchester , UK
– name: 3 Division of Neuroscience & Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health , The University of Manchester , Manchester , UK
– name: 4 The Oxford Institute of Population Ageing , University of Oxford , Oxford , UK
Author_xml – sequence: 1
  givenname: Artitaya
  orcidid: 0000-0003-0550-4657
  surname: Lophatananon
  fullname: Lophatananon, Artitaya
  organization: Division of Population Health, Health Services Research and Primary Care,School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
– sequence: 2
  givenname: Krisztina
  surname: Mekli
  fullname: Mekli, Krisztina
  organization: Division of Population Health, Health Services Research and Primary Care,School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
– sequence: 3
  givenname: Rachel
  surname: Cant
  fullname: Cant, Rachel
  organization: Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
– sequence: 4
  givenname: Alistair
  surname: Burns
  fullname: Burns, Alistair
  organization: Division of Neuroscience & Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
– sequence: 5
  givenname: Curtis
  surname: Dobson
  fullname: Dobson, Curtis
  organization: Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
– sequence: 6
  givenname: Ruth
  surname: Itzhaki
  fullname: Itzhaki, Ruth
  organization: The Oxford Institute of Population Ageing, University of Oxford, Oxford, UK
– sequence: 7
  givenname: Kenneth
  orcidid: 0000-0001-6429-988X
  surname: Muir
  fullname: Muir, Kenneth
  email: kenneth.muir@manchester.ac.uk
  organization: Division of Population Health, Health Services Research and Primary Care,School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34625411$$D View this record in MEDLINE/PubMed
BookMark eNp9UkluFDEULaEgEkJOgIQssWFBEY81sECCiCEiEgvIho3lqbrdcdmN7WqRXcQV4IQ5Ce50B5Is4o2__n_v6f3hcbXjgzdV9RTBVwiR5lCOi7A0vsYQwxpS1rXoQbWHIaV1AxnbuRHvVgcpLWB5lPWM4UfVLqENZhShverX17n1M2fSS_A9pCxW4idYCaWsF9kGD4TXINp0BsIAtFkZF5YFX8LR-GzFayCANykbDZRI5vLitwo-x-BAypM-v7z4E02aXE5giGEEeW7A6WfwzgYp_BlQYR5iflI9HIRL5mD771enH95_O_pUn3z5eHz09qSWpYtcK9xrgRVqaIcbTQjGDPYaSsJIr7UcUNsoAU3JKSyhppARaQpHQ0YZlS3Zr443ujqIBV9GO4p4zoOw_CoR4oyLmK1yhktKCRRwwJoiSlosNaK4QRr1kLa4oUXrzUZrOcnRaFWGEYW7JXq74u2cz8KKdwxSwroi8GIrEMOPqUyQjzYp45zwJkyJY9bBFkKESYE-vwNdhCn6MiqOm4ahsvxu3d2zm47-WbledQH0G4CKIaVoBq5svlpyMWgdR5CvL4tvL4uvL4tvLqtwyR3utfz9rMMNqxT_e76P8RdOb-TM
CitedBy_id crossref_primary_10_1007_s10072_023_07038_7
crossref_primary_10_1016_j_bbi_2024_07_026
crossref_primary_10_1126_scisignal_ado6430
crossref_primary_10_1186_s12889_023_16768_4
crossref_primary_10_3233_JAD_221231
crossref_primary_10_1093_qjmed_hcae103
crossref_primary_10_3233_JAD_220361
crossref_primary_10_3390_ijms26020508
crossref_primary_10_1016_j_vaccine_2024_126673
crossref_primary_10_3233_JAD_220287
crossref_primary_10_1016_j_exger_2024_112411
crossref_primary_10_1080_14760584_2023_2185223
crossref_primary_10_3233_JAD_220955
crossref_primary_10_1186_s13195_024_01418_7
crossref_primary_10_5692_clinicalneurol_cn_002047
crossref_primary_10_1016_j_neuron_2022_12_029
crossref_primary_10_1186_s13195_024_01511_x
crossref_primary_10_1002_cdt3_50
crossref_primary_10_3233_JAD_231323
crossref_primary_10_1016_j_bbih_2024_100743
crossref_primary_10_1016_j_celrep_2024_115109
crossref_primary_10_1097_MD_0000000000034503
crossref_primary_10_1007_s40520_023_02409_8
crossref_primary_10_1212_WNL_0000000000200709
crossref_primary_10_1002_brb3_3407
crossref_primary_10_1007_s11920_024_01514_3
crossref_primary_10_1016_j_bbi_2024_06_020
crossref_primary_10_1080_14737175_2023_2244162
crossref_primary_10_3390_v16010133
crossref_primary_10_3389_fimmu_2022_872542
crossref_primary_10_4103_ds_DS_D_24_00055
crossref_primary_10_1007_s10072_022_06280_9
Cites_doi 10.1371/journal.pone.0096779
10.1093/aje/kwx246
10.1002/psb.1688
10.1007/s10654-019-00499-1
10.1016/j.jalz.2019.07.014
10.4088/JCP.16m11312
10.1007/s004150050078
10.1016/S0140-6736(20)30367-6
10.1002/jmv.1890330403
10.1016/S0140-6736(96)10149-5
10.1016/0002-9343(62)90179-1
10.1056/NEJMc2008597
10.1007/s13365-020-00830-7
10.1007/s00415-002-0874-2
10.2147/CLEP.S282475
10.1002/jmv.23397
10.1016/S1473-3099(03)00857-0
10.1136/bmjopen-2018-023502
10.1371/journal.pone.0188490
10.1186/s13195-017-0241-2
10.1177/15333175211006504
10.1016/s0140-6736(96)10149-5
ContentType Journal Article
Copyright Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021
Copyright_xml – notice: Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
– notice: 2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021
DBID 9YT
ACMMV
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88E
88G
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
BTHHO
CCPQU
COVID
DWQXO
FYUFA
GHDGH
GNUQQ
K9-
K9.
KB0
M0R
M0S
M1P
M2M
NAPCQ
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PSYQQ
Q9U
7X8
5PM
DOA
DOI 10.1136/bmjopen-2020-045871
DatabaseName BMJ Open Access Journals
BMJ Journals:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
BMJ Journals
ProQuest One Community College
Coronavirus Research Database
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Consumer Health Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Consumer Health Database
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Psychology Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Family Health (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest Family Health
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: ACMMV
  name: BMJ Journals:Open Access
  url: https://journals.bmj.com/
  sourceTypes: Publisher
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 2044-6055
ExternalDocumentID oai_doaj_org_article_b4430a0f2d414372bd14261d19047264
PMC8504358
34625411
10_1136_bmjopen_2020_045871
bmjopen
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United Kingdom
United Kingdom--UK
GeographicLocations_xml – name: United Kingdom
– name: United Kingdom--UK
GrantInformation_xml – fundername: The Advantage Foundation
  grantid: 106529/190624
– fundername: Medical Research Council
  grantid: MC_PC_17228
– fundername: Medical Research Council
  grantid: MC_QA137853
– fundername: ;
  grantid: 106529/190624
GroupedDBID ---
4.4
53G
5VS
7RV
7X7
7~R
88E
8FI
8FJ
9YT
ABUWG
ACGFS
ACMMV
ADBBV
AENEX
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BKNYI
BPHCQ
BTFSW
BTHHO
CCPQU
DIK
DWQXO
EBS
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
HZ~
K9-
KQ8
M0R
M1P
M2M
M48
M~E
NAPCQ
O9-
OK1
PGMZT
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PSYQQ
RHI
RMJ
RPM
UKHRP
AAYXX
ADRAZ
BVXVI
CITATION
EJD
PHGZM
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
3V.
7XB
8FK
COVID
K9.
PKEHL
PQEST
PQUKI
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-b605t-c29da2c164826d3322509d0b3539ddbf176ca0e09dc2b0d4053be29dd05454b73
IEDL.DBID M48
ISSN 2044-6055
IngestDate Wed Aug 27 01:20:31 EDT 2025
Thu Aug 21 18:05:29 EDT 2025
Thu Sep 04 22:04:15 EDT 2025
Fri Jul 25 10:51:14 EDT 2025
Mon Jul 21 06:03:14 EDT 2025
Tue Jul 01 02:44:32 EDT 2025
Thu Apr 24 23:00:17 EDT 2025
Thu Apr 24 22:50:05 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords epidemiology
dementia
public health
Language English
License This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b605t-c29da2c164826d3322509d0b3539ddbf176ca0e09dc2b0d4053be29dd05454b73
Notes Original research
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
CD, RI and KM are joint senior authors.
ORCID 0000-0001-6429-988X
0000-0003-0550-4657
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1136/bmjopen-2020-045871
PMID 34625411
PQID 2665145887
PQPubID 2040975
ParticipantIDs doaj_primary_oai_doaj_org_article_b4430a0f2d414372bd14261d19047264
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8504358
proquest_miscellaneous_2580700123
proquest_journals_2665145887
pubmed_primary_34625411
crossref_citationtrail_10_1136_bmjopen_2020_045871
crossref_primary_10_1136_bmjopen_2020_045871
bmj_journals_10_1136_bmjopen_2020_045871
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-10-08
PublicationDateYYYYMMDD 2021-10-08
PublicationDate_xml – month: 10
  year: 2021
  text: 2021-10-08
  day: 08
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
– name: BMA House, Tavistock Square, London, WC1H 9JR
PublicationSeriesTitle Original research
PublicationTitle BMJ open
PublicationTitleAbbrev BMJ Open
PublicationTitleAlternate BMJ Open
PublicationYear 2021
Publisher British Medical Journal Publishing Group
BMJ Publishing Group LTD
BMJ Publishing Group
Publisher_xml – name: British Medical Journal Publishing Group
– name: BMJ Publishing Group LTD
– name: BMJ Publishing Group
References Thomas, Hall (R14) 2004; 4
Wetzel, Asholt, Herrmann (R17) 2002; 249
Westman, Berglund, Widén (R5) 2014; 9
Wilkinson, Schnier, Bush (R8) 2019; 34
Curran, Hunjan, El Ghachi (R13) 2019; 9
Grahn, Bauer, Silver (R18) 2013; 54
Helms, Kremer, Merdji (R23) 2020; 382
Stowe, Peek, Cutchin (R4) 2012; 84
Dowden (R7) 2018; 29
Choi, Park, Lim (R11) 2021; 36
Itzhaki, Lin, Shang (R3) 1997; 349
Ludvigsson, Appelros, Askling (R10) 2021; 13
Hokkanen, Launes, Poutiainen (R16) 1997; 244
Calvin, Wilkinson, Starr (R12) 2019; 15
Bubak, Beseler, Como (R6) 2020; 26
Jamieson, Maitland, Wilcock (R2) 1991; 33
Chen, Wu, Huang (R20) 2018; 79
Tsai, Cheng, Sheu (R19) 2017; 12
Fry, Littlejohns, Sudlow (R26) 2017; 186
McManus, Heneka (R24) 2017; 9
Livingston, Huntley, Sommerlad (R1) 2020; 396
Verreault, Laurin, Lindsay (R22) 2001; 165
Appelbaum, Kreps, Sunshine (R15) 1962; 32
Itzhaki, Dobson (R21) 2002; 167
2024102817410846000_11.10.e045871.14
2024102817410846000_11.10.e045871.1
2024102817410846000_11.10.e045871.15
2024102817410846000_11.10.e045871.8
2024102817410846000_11.10.e045871.9
Bubak (2024102817410846000_11.10.e045871.6) 2020; 26
Dowden (2024102817410846000_11.10.e045871.7) 2018; 29
2024102817410846000_11.10.e045871.4
Calvin (2024102817410846000_11.10.e045871.12) 2019; 15
2024102817410846000_11.10.e045871.2
2024102817410846000_11.10.e045871.3
Curran (2024102817410846000_11.10.e045871.13) 2019; 9
2024102817410846000_11.10.e045871.25
Wetzel (2024102817410846000_11.10.e045871.17) 2002; 249
Chen (2024102817410846000_11.10.e045871.20) 2018; 79
2024102817410846000_11.10.e045871.26
Ludvigsson (2024102817410846000_11.10.e045871.10) 2021; 13
Hokkanen (2024102817410846000_11.10.e045871.16) 1997; 244
Itzhaki (2024102817410846000_11.10.e045871.21) 2002; 167
Choi (2024102817410846000_11.10.e045871.11) 2021; 36
Westman (2024102817410846000_11.10.e045871.5) 2014; 9
Tsai (2024102817410846000_11.10.e045871.19) 2017; 12
Verreault (2024102817410846000_11.10.e045871.22) 2001; 165
McManus (2024102817410846000_11.10.e045871.24) 2017; 9
Helms (2024102817410846000_11.10.e045871.23) 2020; 382
Grahn (2024102817410846000_11.10.e045871.18) 2013; 54
References_xml – volume: 9
  year: 2014
  ident: R5
  article-title: Increased inflammatory response in cytomegalovirus seropositive patients with Alzheimer’s disease
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0096779
– volume: 186
  start-page: 1026
  year: 2017
  ident: R26
  article-title: Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwx246
– volume: 29
  start-page: 23
  year: 2018
  ident: R7
  article-title: Is the UK shingles vaccination programme fit for the future?
  publication-title: Prescriber
  doi: 10.1002/psb.1688
– volume: 34
  start-page: 557
  year: 2019
  ident: R8
  article-title: Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data
  publication-title: Eur J Epidemiol
  doi: 10.1007/s10654-019-00499-1
– volume: 15
  start-page: 1546
  year: 2019
  ident: R12
  article-title: Predicting incident dementia 3-8 years after brief cognitive tests in the UK Biobank prospective study of 500,000 people
  publication-title: Alzheimer's & Dementia
  doi: 10.1016/j.jalz.2019.07.014
– volume: 36
  year: 2021
  ident: R11
  article-title: Herpes zoster does not increase the risk of neurodegenerative dementia: a case-control study
  publication-title: American Journal of Alzheimer’s Disease and Other Dementias
– volume: 79
  year: 2018
  ident: R20
  article-title: Herpes zoster and dementia: a nationwide population-based cohort study
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.16m11312
– volume: 165
  start-page: 1495
  year: 2001
  ident: R22
  article-title: Past exposure to vaccines and subsequent risk of Alzheimer's disease
  publication-title: CMAJ
– volume: 244
  start-page: 239
  year: 1997
  ident: R16
  article-title: Subcortical type cognitive impairment in herpes zoster encephalitis
  publication-title: J Neurol
  doi: 10.1007/s004150050078
– volume: 396
  start-page: 413
  year: 2020
  ident: R1
  article-title: Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30367-6
– volume: 33
  start-page: 224
  year: 1991
  ident: R2
  article-title: Latent herpes simplex virus type 1 in normal and Alzheimer’s disease brains
  publication-title: J Med Virol
  doi: 10.1002/jmv.1890330403
– volume: 349
  start-page: 241
  year: 1997
  ident: R3
  article-title: Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease
  publication-title: The Lancet
  doi: 10.1016/S0140-6736(96)10149-5
– volume: 32
  start-page: 25
  year: 1962
  ident: R15
  article-title: Herpes zoster encephalitis
  publication-title: Am J Med
  doi: 10.1016/0002-9343(62)90179-1
– volume: 382
  start-page: 2268
  year: 2020
  ident: R23
  article-title: Neurologic features in severe SARS-CoV-2 infection
  publication-title: N Engl J Med Overseas Ed
  doi: 10.1056/NEJMc2008597
– volume: 26
  start-page: 422
  year: 2020
  ident: R6
  article-title: Acute zoster plasma contains elevated amyloid, correlating with Aβ42 and amylin levels, and is amyloidogenic
  publication-title: J Neurovirol
  doi: 10.1007/s13365-020-00830-7
– volume: 249
  start-page: 1612
  year: 2002
  ident: R17
  article-title: Good cognitive outcome of patients with herpes zoster encephalitis: a follow-up study
  publication-title: J Neurol
  doi: 10.1007/s00415-002-0874-2
– volume: 54
  start-page: 86
  year: 2013
  ident: R18
  article-title: Diagnostic ophthalmology
  publication-title: Can Vet J
– volume: 167
  start-page: 13
  year: 2002
  ident: R21
  article-title: Alzheimer's disease and herpes
  publication-title: CMAJ
– volume: 13
  start-page: 21
  year: 2021
  ident: R10
  article-title: Adaptation of the Charlson comorbidity index for register-based research in Sweden
  publication-title: Clinical epidemiology
  doi: 10.2147/CLEP.S282475
– volume: 84
  start-page: 1797
  year: 2012
  ident: R4
  article-title: Reactivation of herpes simplex virus type 1 is associated with cytomegalovirus and age
  publication-title: J Med Virol
  doi: 10.1002/jmv.23397
– volume: 4
  start-page: 26
  year: 2004
  ident: R14
  article-title: What does epidemiology tell us about risk factors for herpes zoster?
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(03)00857-0
– volume: 9
  year: 2019
  ident: R13
  article-title: Herpes zoster related healthcare burden and costs in immunocompromised (IC) and IC-free populations in England: an observational retrospective database analysis
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2018-023502
– volume: 12
  year: 2017
  ident: R19
  article-title: Increased risk of dementia following herpes zoster ophthalmicus
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0188490
– volume: 9
  start-page: 14
  year: 2017
  ident: R24
  article-title: Role of neuroinflammation in neurodegeneration: new insights
  publication-title: Alzheimers Res Ther
  doi: 10.1186/s13195-017-0241-2
– volume: 36
  year: 2021
  ident: 2024102817410846000_11.10.e045871.11
  article-title: Herpes zoster does not increase the risk of neurodegenerative dementia: a case-control study
  publication-title: American Journal of Alzheimer’s Disease and Other Dementias
  doi: 10.1177/15333175211006504
– ident: 2024102817410846000_11.10.e045871.3
  doi: 10.1016/s0140-6736(96)10149-5
– ident: 2024102817410846000_11.10.e045871.15
  doi: 10.1016/0002-9343(62)90179-1
– volume: 382
  start-page: 2268
  year: 2020
  ident: 2024102817410846000_11.10.e045871.23
  article-title: Neurologic features in severe SARS-CoV-2 infection
  publication-title: N Engl J Med Overseas Ed
  doi: 10.1056/NEJMc2008597
– ident: 2024102817410846000_11.10.e045871.26
  doi: 10.1093/aje/kwx246
– volume: 165
  start-page: 1495
  year: 2001
  ident: 2024102817410846000_11.10.e045871.22
  article-title: Past exposure to vaccines and subsequent risk of Alzheimer's disease
  publication-title: CMAJ
– ident: 2024102817410846000_11.10.e045871.1
  doi: 10.1016/S0140-6736(20)30367-6
– volume: 13
  start-page: 21
  year: 2021
  ident: 2024102817410846000_11.10.e045871.10
  article-title: Adaptation of the Charlson comorbidity index for register-based research in Sweden
  publication-title: Clinical epidemiology
  doi: 10.2147/CLEP.S282475
– volume: 15
  start-page: 1546
  year: 2019
  ident: 2024102817410846000_11.10.e045871.12
  article-title: Predicting incident dementia 3-8 years after brief cognitive tests in the UK Biobank prospective study of 500,000 people
  publication-title: Alzheimer's & Dementia
  doi: 10.1016/j.jalz.2019.07.014
– volume: 26
  start-page: 422
  year: 2020
  ident: 2024102817410846000_11.10.e045871.6
  article-title: Acute zoster plasma contains elevated amyloid, correlating with Aβ42 and amylin levels, and is amyloidogenic
  publication-title: J Neurovirol
  doi: 10.1007/s13365-020-00830-7
– volume: 12
  year: 2017
  ident: 2024102817410846000_11.10.e045871.19
  article-title: Increased risk of dementia following herpes zoster ophthalmicus
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0188490
– ident: 2024102817410846000_11.10.e045871.14
  doi: 10.1016/S1473-3099(03)00857-0
– volume: 79
  year: 2018
  ident: 2024102817410846000_11.10.e045871.20
  article-title: Herpes zoster and dementia: a nationwide population-based cohort study
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.16m11312
– volume: 9
  year: 2014
  ident: 2024102817410846000_11.10.e045871.5
  article-title: Increased inflammatory response in cytomegalovirus seropositive patients with Alzheimer’s disease
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0096779
– volume: 9
  start-page: 14
  year: 2017
  ident: 2024102817410846000_11.10.e045871.24
  article-title: Role of neuroinflammation in neurodegeneration: new insights
  publication-title: Alzheimers Res Ther
  doi: 10.1186/s13195-017-0241-2
– volume: 54
  start-page: 86
  year: 2013
  ident: 2024102817410846000_11.10.e045871.18
  article-title: Diagnostic ophthalmology
  publication-title: Can Vet J
– ident: 2024102817410846000_11.10.e045871.8
  doi: 10.1007/s10654-019-00499-1
– volume: 29
  start-page: 23
  year: 2018
  ident: 2024102817410846000_11.10.e045871.7
  article-title: Is the UK shingles vaccination programme fit for the future?
  publication-title: Prescriber
  doi: 10.1002/psb.1688
– ident: 2024102817410846000_11.10.e045871.2
  doi: 10.1002/jmv.1890330403
– ident: 2024102817410846000_11.10.e045871.9
– volume: 244
  start-page: 239
  year: 1997
  ident: 2024102817410846000_11.10.e045871.16
  article-title: Subcortical type cognitive impairment in herpes zoster encephalitis
  publication-title: J Neurol
  doi: 10.1007/s004150050078
– ident: 2024102817410846000_11.10.e045871.4
  doi: 10.1002/jmv.23397
– volume: 249
  start-page: 1612
  year: 2002
  ident: 2024102817410846000_11.10.e045871.17
  article-title: Good cognitive outcome of patients with herpes zoster encephalitis: a follow-up study
  publication-title: J Neurol
  doi: 10.1007/s00415-002-0874-2
– volume: 167
  start-page: 13
  year: 2002
  ident: 2024102817410846000_11.10.e045871.21
  article-title: Alzheimer's disease and herpes
  publication-title: CMAJ
– volume: 9
  year: 2019
  ident: 2024102817410846000_11.10.e045871.13
  article-title: Herpes zoster related healthcare burden and costs in immunocompromised (IC) and IC-free populations in England: an observational retrospective database analysis
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2018-023502
– ident: 2024102817410846000_11.10.e045871.25
SSID ssj0000459552
Score 2.462471
Snippet ObjectivesTo investigate the association between shingles and dementia, and between Zostavax vaccination and dementia.DesignNested case–control...
To investigate the association between shingles and dementia, and between Zostavax vaccination and dementia. Nested case-control study. Data were drawn from...
To investigate the association between shingles and dementia, and between Zostavax vaccination and dementia.OBJECTIVESTo investigate the association between...
Objectives To investigate the association between shingles and dementia, and between Zostavax vaccination and dementia.Design Nested case–control...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
bmj
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e045871
SubjectTerms Age
Alzheimer's disease
Biobanks
Biological Specimen Banks
Brain research
Case-Control Studies
Chicken pox
Codes
Cohort Studies
Cytomegalovirus
Datasets
Dementia
Dementia - epidemiology
Epidemiology
Herpes viruses
Herpes Zoster
Herpes Zoster Vaccine
Humans
Immunization
Investigations
Primary care
public health
United Kingdom - epidemiology
Vaccination
Vaccines
SummonAdditionalLinks – databaseName: BMJ Open Access Journals
  dbid: 9YT
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbtQwEB61RaoqVQjKTwMFGYkDh6Z1_JNsuFFEVYHgQlcqXCLHdkphSdButuJY8QrwhH0SZpxkyyJUcUqUjC0n4xl_Mx7PADwdWelELmxsKVRcZd6hHpQiTlOvUDVIj1eKtniXHo3V6xN9sgJiOAtTfv1MZaP28NqdaKAcTXW7nyQo3_uetvWyZI9c06twg3JxURhf_uF44VdBilyHQjuCKxUjWtd9sqFEpkP3ODcERTVSZxuwLhVaAYqKCK0iwdIKFRL5_wt9_h1E-ceqdHgLbvZwkr3o-H8bVny9Betv-w3zLdjs3HKsO210B368J4_TxM922ccGgeG5-c7OjUXiwCFmasco2pw1Fbs6T4W3IarIPGeG1cFDyiwuf5cXP_tQdxbS1F5e_ELrfT5pZ4yOrTAEl2z8hh2codKovzAqxjtt78L48NXxy6O4L8MQl_j32tiK3Blh0a5CU8RJ0gA8d7yUWubOlVWSpdZwj8-sKLlDBChLj20cokGtykzeg7W6qf02MGm5lFp5622lsio12LNDm0lnPBNOpRE8QwYUvRjNimChyLTo2VYQ24qObRGIgUuF7dOZU1WNyfWNdheNvnXZPK4nPyD2L0gpFXd40ExPi16yi1IpyQ2vcPwJbYKWLiGz1CHSUhnCzQh2hslz9WEIixCpatTwETxZvEbJpu0aU_tmjjR6xLOAeSO43821xUiGGRtBtjQLl4a6_KY--xSyh48oZ50ePfj_X_0QNgRF8oTIxx1Ya6dz_wihWFs-DrL3G2XZLkU
  priority: 102
  providerName: BMJ Publishing Group Ltd
– databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZKDxUXVGiB0IKMxKGHRnX8iBNuFFFVoHKBlSoukV8RbbdZ1M1WHCv-AvzC_hJmHHe7i1C5cErkR-RkxuNv4s8zhLyqnPC85i53SBWXOniwg4LnZRkkmAYR4Ipsi4_l4Ui-P1bHC6m-kBM2hAcePtyelVIww1ruZYF7TNYXiPo9LGRSw2qO1pfVbMGZijZYqlopnsIMFaLcs-enmI8KtIIjn1FVeGj-HpQuLUgxbv_fwOafnMmFRehgnTxI6JG-GUb9kKyE7hFZO0r74xvkxyf8oTQO0136ZQK479J8p5fGQWUUADWdp0gmp5OW3h6XgttIGjKvqaFd_AFKHaxu11c_E5Odxii011e_wDmfjfspxVMpFLAjHX2g-ydgE7ozirl2L_pNMjp49_ntYZ6yLOQWXJk-d7z2hjtwm8DT8AInOKs9s0KJ2nvbFrp0hgUoc9wyDwBP2AB9PIA9Ja0Wj8lqN-nCU0KFY0IoGVxwrdRtaeDJHlwipZkG-ZUZ2YEP3qRZMm2iAyLKJsmmQdk0g2wywm-k0rgUrRyTZozv7rQ77_RtCNZxd_N9FPe8KUbajgWgf03Sv-Zf-peR7RtluX0xQD0ARBUY8Iy8nFfDxMXdGNOFyQzaqIrpCGkz8mTQrflIhAS3VBYwQr2kdUtDXa7pTr7G4OAVhqRT1bP_8W5b5D5HCk-kPG6T1f5iFp4DBuvtizjdfgMl1y6H
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9NAEF7RIiEuqLwNBS0SBw61au_Da_eCKKKqQHCBSBEXa1-GQrBL4lQ9Vv0L8Av7S5jZbByCUE6O9mGNMzsz3-zOzhDyvLTcsYrZ1GKouFDegR7kLC0KL0A1cA9PjLb4UByPxNuxHMcNt1kMq1zqxKCoXWdxj3wfDAnYdgky8fL0Z4pVo_B0NZbQ2CLXc0AiWLpBjdWwxwJwpZKSxWRDOS_2zY9vWJUK1gbDqEZZ4tX5LWhdM0she___IOe_kZN_maKjHXIrYkj6asH02-Sab--QG-_jKfldcvkRt5UmfrZHP3eA_s70OT3TFjoDG6huHcWQcto1dHVpCn6G0CF9QDVtwzYotWDjri5-xXh2GnLRXl38Bhd9PulnFO-mUECQdPSOHp6AZmi_U6y4O-3vkdHRm0-vj9NYayE14ND0qWWV08yC8wT-huMo5lnlMsMlr5wzTa4KqzMPbZaZzAHM48bDHAeQTwqj-H2y3Xatf0gotxnnUnjrbSNUU2h4swPHSKpMMSeKhLyAP7yOsjKrgxvCizrypkbe1AveJIQtuVLbmLMcS2dMNk_aGyadLlJ2bB5-iOwehmK-7dDQTb_UUXxrIwTPdNYA_TmedBqXo-_pAE4JBZgyIbvLxbL6sNWSTcizoRvEF89kdOu7OYyRZaYCsE3Ig8XaGijhApxTkQOFam3VrZG63tOefA0pwktMTCfLR5vJekxuMgzRCSGNu2S7n879E8BYvXkaBOkP5M4oEQ
  priority: 102
  providerName: ProQuest
Title Shingles, Zostavax vaccination and risk of developing dementia: a nested case–control study—results from the UK Biobank cohort
URI https://bmjopen.bmj.com/content/11/10/e045871.full
https://www.ncbi.nlm.nih.gov/pubmed/34625411
https://www.proquest.com/docview/2665145887
https://www.proquest.com/docview/2580700123
https://pubmed.ncbi.nlm.nih.gov/PMC8504358
https://doaj.org/article/b4430a0f2d414372bd14261d19047264
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZKKyEuiDeBsjISBw5dSPyIEySEulVLBdoKQRctXKL4ESgsCexmq3Kr-AvwC_tLmPF6tywqPXFJIj8iJ-Oxv7E_zxDyIDPcspyZrkGquFDOwjjIWTdNnYChgTu4I9tiL90diBdDOVwh86io4QdOzjTtMJ7UYDx6dPTt-zNQ-KchIslj_eUTZoHAGVIVZYZnytf8hhFy-QLe90OzkLmULHgf-kddmGUgdWme8u78z8Kgf1Mp_5ibdq6QywFU0s1ZL7hKVlx9jVzsh23z6-THG1xnGrnJBn3fABw8LI_oYWkg08uFlrWlyDGnTUVPT1HBo-cSlU9oSWu_LkoNTHonxz8DwZ1657Qnx7_AZp-O2gnFwyoUICUdvKS9Axgq6s8UQ_CO2xtksLO9v7XbDcEXuhosnLZrWG5LZsCaAgPEctT7OLex5pLn1uoqUakpYwdphunYAu7j2kEdCxhQCq34TbJaN7W7TSg3MedSOONMJVSVlvBmC5aSVLFiVqQReQg_vJjLvvB2CU-LIJsCZVPMZBMRNpdKYYITc4ylMTq_0sai0teZD4_zi_dQ3Iui6IDbJzTjD0XQ50ILweMyrqD9CW59apugMWoBXwkFIDMi6_POcvphAIYAn0oY1yNyf5EN-oybNGXtmimUkVmsPNKNyK1Z31q0hAuwVkUCLVRLvW6pqcs59cFH7zM8Q091MrvzP77tLrnEkNnjmZDrZLUdT909gGat7pALaqjgmr_b75C1za1-_y3ce9t7r153_HIHXJ8Pk45Xy9_l0z-p
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB61RQIuiDeBAosEEodatffhTZAQokCVkrYXGiniYta7GygEu-RR4FbxF-B38KP6S5jZOA5BKLeebO3DmmQe-83u7AzAw6YVjre4jSyFikvtHdpBwaM09RJNg_D4pGiL_bTdla97qrcCv2d3YSiscmYTg6F2paU98k1cSHBtV6gTz46-RFQ1ik5XZyU0pmLR8d-_oss2errzEvn7iPPtVwcv2lFVVSDKEbqPI8tbznCLbgIiaydIoOOWi3OhRMu5vJ_o1JrYY5vleewQ0Ijc4xyH4EbJXAv87iqck3TEiPqje7re08GWllK8Sm6UiHQz__yRqmChLHKKolRNuqq_iq0Ly2CoFvA_iPtvpOZfS9_2ZbhUYVb2fCpkV2DFF1fh_F51Kn8NfryhbayBH22wtyWizWPzjR0bi52B7cwUjlEIOyv7bH5JC19DqJJ5wgwrwrYrs7imnp78rOLnWch9e3rya-hHk8F4xOguDEPEyrodtnWIlqj4xKjC73B8HbpnwoUbsFaUhb8FTNhYCCW99bYvdT81-GWHjpjSseZOpg14jH94VunmKAtuj0izijcZ8Sab8qYBfMaVzFY50qlUx2D5pI160tE0Rcjy4VvE7noo5fcODeXwfVaZiyyXKF8m7iP9CZ2s5i4hX9chfJMaMWwD1mfCMv9hcxVpwIO6G80FnQGZwpcTHKOasQ5AugE3p7JVUyIkOsMyQQr1gtQtkLrYUxx-CCnJm5QITzVvLyfrPlxoH-ztZrs7-507cJFTeFAIp1yHtfFw4u8ivhvn94JSMXh31lr8B5YdZCA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZ2kSZeEHc6BhgJJB4WNfUlF6QJUbZqo1BNQKWJl5DYDnSUZPQy4G3iL8Cv4mfsl3CO66QUob7tKZFjR07O7Tv28TmEPIwU1yxmylMYKi5Co0EPcuYFgRGgGriBK0Zb9IL9vnhxJI9WyO_qLAyGVVY60SpqXSpcI2-CIQHbLkEmmrkLizjc7Tw9-eJhBSncaa3KaaSuzILesenG3CGPrvn-Fdy58c7BLtD-EWOdvbfP9z1XccDLANZPPMVinTIFLgSgbs2R2f1Y-xmXPNY6y1thoFLfQJtima8B7PDMwBgNwEeKLOTw3lWyHoLVB0dwvb3XO3xdr_gAeIqlZC71UYsHzezzMdbIAk5lGGMpIzzIvwqtC0bS1hL4HwD-N47zL8PYuUIuO0RLn81Y8CpZMcU1svHK7dlfJz_e4CLX0Iy36bsSsOhp-o2ewt8bzNYhaVpoigHutMzp_AgX3NpApvQJTWlhF2WpAot7fvbTRddTmxn3_OzXyIynw8mY4kkZCniW9ru0PQA9VXyiWP93NLlB-hdCh5tkrSgLc5tQrnzOpTDKqFyEeZDCmzW4aTL0Q6ZF0CCP4YcnTnLHiXWKeJA42iRIm2RGmwZhFVUS5TKoYyGP4fJB2_Wgk1kCkeXd20juuitm_7YN5ehD4pRJkgnB_dTPYf4t3HfNdAs9YQ3gToSAcBtkq2KW-YfNBahBHtSPQZngDlFamHIKfWTkhxZmN8itGW_VM-ECXGXRghmGC1y3MNXFJ8Xgo01YHmGaPBltLp_WfbIBEp28POh175BLDGOHbKzlFlmbjKbmLoC_SXbPSRUl7y9akP8AAtBu-w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Shingles%2C+Zostavax+vaccination+and+risk+of+developing+dementia%3A+a+nested+case%E2%80%93control+study%E2%80%94results+from+the+UK+Biobank+cohort&rft.jtitle=BMJ+open&rft.au=Alistair+Burns&rft.au=Artitaya+Lophatananon&rft.au=Kenneth+Muir&rft.au=Rachel+Cant&rft.date=2021-10-08&rft.pub=BMJ+Publishing+Group&rft.eissn=2044-6055&rft.volume=11&rft.issue=10&rft_id=info:doi/10.1136%2Fbmjopen-2020-045871&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_b4430a0f2d414372bd14261d19047264
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2044-6055&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2044-6055&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2044-6055&client=summon